UBS Group AG - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 48 filers reported holding ANGION BIOMEDICA CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$8,406
+4.6%
14,492
+46.1%
0.00%
Q4 2022$8,035
+14.8%
9,919
+37.0%
0.00%
Q3 2022$7,000
-41.7%
7,240
-34.0%
0.00%
Q2 2022$12,000
+1100.0%
10,969
+2253.9%
0.00%
Q1 2022$1,000
-96.0%
466
-94.5%
0.00%
Q4 2021$25,000
+733.3%
8,537
+3834.1%
0.00%
Q2 2021$3,000
-89.7%
217
-86.7%
0.00%
Q1 2021$29,0001,6300.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 525,000$599,0000.64%
Nantahala Capital Management 1,131,001$1,289,0000.06%
BVF INC/IL 1,071,297$1,221,0000.06%
Birchview Capital, LP 54,392$62,0000.04%
Knoll Capital Management, LLC 60,000$68,0000.04%
Ground Swell Capital, LLC 16,258$19,0000.04%
LAKE STREET ADVISORS GROUP, LLC 246,904$282,0000.02%
Patriot Financial Group Insurance Agency, LLC 36,500$41,0000.01%
BLB&B Advisors, LLC 56,847$65,0000.01%
Park West Asset Management LLC 75,503$86,0000.01%
View complete list of ANGION BIOMEDICA CORP shareholders